Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DM3MDOL)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
phenazopyridine; Pyridiate; Gastracid; 94-78-0; Baridium; Pyrazofen; Urogesic; 3-(Phenylazo)-2,6-pyridinediamine; Geridium; Gastrotest; Viridium; 2,6-Pyridinediamine, 3-(phenylazo)-; Pyridacil; Fenazopiridina; Eridium; 2,6-Diamino-3-phenylazopyridine; Phenazopyridinum; 2,6-Diamino-3-(phenylazo)pyridine; Phenazopyridine [INN:BAN]; UNII-K2J09EMJ52; Phenazopyridinum [INN-Latin]; Fenazopiridina [INN-Spanish]; NSC 145895; HSDB 3153; EINECS 202-363-2; BRN 0184497; 3-(phenyldiazenyl)pyridine-2,6-diamine; Pyridine, 2,6-diamino-3-(phenylazo)-
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
